Sign in
4/A

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0002111813-26-000008

Options or other derivatives

  • President and CEO acquired 149,965.43 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Parikh Anand Kiran President and CEO 2026-02-17 Grant or award · Series B Preferred Stock +761.43 761,428 D
Parikh Anand Kiran President and CEO 2026-02-17 Grant or award · Employee Stock Option (right to buy) +12,320 12,320 D
Parikh Anand Kiran President and CEO 2026-02-17 Grant or award · Employee Stock Option (right to buy) +136,884 136,884 D
Loading xslF345X06/form4a-06162026_080634.xml…